Andrew Mortlock Email & Phone Number
Executive Vice President and Head of Early Development and Translational Science @ アステラス製薬（株）
5 free lookup(s). No credit card required.
If you need more lookups,
subscriptions start at $34 USD/month.
Andrew Mortlock Location
- England, United Kingdom
Andrew Mortlock Work
- Executive Vice President and Head of Early Development and Translational Science @ (July 2023 - Present)
- VP, Global Franchise Head for PARP1 selective and Ceralasertib @ (November 2021 - April 2023)
- Cancer Research Scientist @ (January 1992 - April 2023)
- Vice President Haematology Projects, AstraZeneca Oncology and Chief Scientific Officer, Acerta Pharma @ (July 2020 - January 2022)
- Vice President Global Projects (AstraZeneca(, Chief Scientific Officer (Acerta Pharma) @ (May 2016 - July 2020)
- VP Oncology Projects and Alliances @ (November 1992 - July 2020)
- Cancer scientist @ (January 1992 - July 2020)
- post-doc @ (October 1991 - November 1992)
Andrew Mortlock Education
- University of California, Berkeley
post-doc (chemistry)
1991-1992 - University of Oxford
MA D Phil (Chemistry)
1984-1991
Andrew Mortlock Skills
- Cancer
- Drug Discovery
- Biotechnology
- Oncology
- Lifesciences
- Cancer Research
- Drug Development
- Biomarkers
- Pharmaceutical Research
- R&D
- Organic Chemistry
- Medicinal Chemistry
- Drug Design
- In Vitro
- Neuroscience
- Molecular Biology
- Lead Change
- Pharmaceutical Industry
- NMR
- HPLC
- Chemistry
- Organic Synthesis
- Biochemistry
- Mass Spectrometry
- Chromatography
- Clinical Development
- Pharmacology
- Analytical Chemistry
- Clinical Trials
- LC-MS
- Protein Chemistry
- Clinical Research
- Life Sciences
- Fixed Income
- Data Analysis
- Business Development
- Marketing
- Lc Ms
- Research
- Science
- Pharmaceutical Sales
- Middle Office
- Strategic Planning
- Leadership
- Customer Service
Andrew Mortlock Summary
- Andrew Mortlock, based in England, United Kingdom, is currently a Executive Vice President and Head of Early Development and Translational Science at Astellas Pharma. Andrew Mortlock brings experience from previous roles at AstraZeneca. Andrew Mortlock holds a 1991 - 1992 post-doc in chemistry @ University of California, Berkeley. With a robust skill set that includes Cancer, Drug Discovery, Biotechnology, Oncology, Lifesciences and more. Andrew Mortlock has 2 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Andrew Mortlock?
Find contact details for 700 million professionals.
Others Named Andrew Mortlock
Andrew Mortlock
CEO
Sydney, NSW, AU
Andrew Mortlock
Vice President Haematology Projects, Astrazeneca Oncology and Chief Scientific Officer, Acerta Pharma
Cambridge, Cambridgeshire, United Kingdom
Top アステラス製薬（株） Employees
Judith Nelissen
VP, Head Global Value Evidence
Arnhem-Nijmegen Metropolitan, GE, NL
Andrew Mortlock
Executive Vice President and Head of Early Development and Translational Science
England, United Kingdom
Michael Murphy
Senior Vice President
United States
Ryo Tainaka
Vice President
Tokyo, JP
Atsushi Kitamura
CFO
Tokyo, JP
Katsuyoshi Sugita
CPO
Tokyo, JP
G2 Crowd Trusted
300K+ Plugin Users
© 2026 RocketReach.co